Table of Content

1 Hemophilia A Drug Market Overview
1.1 Hemophilia A Drug Product Scope
1.2 Hemophilia A Drug Segment by Type
1.2.1 Global Hemophilia A Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Hemophilia A Drug Segment by Application
1.3.1 Global Hemophilia A Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Hemophilia A Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hemophilia A Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hemophilia A Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hemophilia A Drug Price Trends (2016-2027)

2 Hemophilia A Drug Estimates and Forecasts by Region
2.1 Global Hemophilia A Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hemophilia A Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hemophilia A Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Hemophilia A Drug Revenue Market Share by Region (2016-2021)
2.3 Global Hemophilia A Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hemophilia A Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hemophilia A Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hemophilia A Drug Estimates and Projections (2016-2027)
2.4.2 Europe Hemophilia A Drug Estimates and Projections (2016-2027)
2.4.3 China Hemophilia A Drug Estimates and Projections (2016-2027)
2.4.4 Japan Hemophilia A Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hemophilia A Drug Estimates and Projections (2016-2027)
2.4.6 India Hemophilia A Drug Estimates and Projections (2016-2027)

3 Global Hemophilia A Drug Competition Landscape by Players
3.1 Global Top Hemophilia A Drug Players by Sales (2016-2021)
3.2 Global Top Hemophilia A Drug Players by Revenue (2016-2021)
3.3 Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemophilia A Drug as of 2020)
3.4 Global Hemophilia A Drug Average Price by Company (2016-2021)
3.5 Manufacturers Hemophilia A Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Hemophilia A Drug Market Size by Type
4.1 Global Hemophilia A Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Hemophilia A Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Hemophilia A Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Hemophilia A Drug Price by Type (2016-2021)
4.2 Global Hemophilia A Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hemophilia A Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Hemophilia A Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Hemophilia A Drug Price Forecast by Type (2022-2027)

5 Global Hemophilia A Drug Market Size by Application
5.1 Global Hemophilia A Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Hemophilia A Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Hemophilia A Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Hemophilia A Drug Price by Application (2016-2021)
5.2 Global Hemophilia A Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hemophilia A Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Hemophilia A Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Hemophilia A Drug Price Forecast by Application (2022-2027)

6 North America Hemophilia A Drug Market Facts & Figures
6.1 North America Hemophilia A Drug Sales by Company
6.1.1 North America Hemophilia A Drug Sales by Company (2016-2021)
6.1.2 North America Hemophilia A Drug Revenue by Company (2016-2021)
6.2 North America Hemophilia A Drug Sales Breakdown by Type
6.2.1 North America Hemophilia A Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Hemophilia A Drug Sales Breakdown by Type (2022-2027)
6.3 North America Hemophilia A Drug Sales Breakdown by Application
6.3.1 North America Hemophilia A Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Hemophilia A Drug Sales Breakdown by Application (2022-2027)

7 Europe Hemophilia A Drug Market Facts & Figures
7.1 Europe Hemophilia A Drug Sales by Company
7.1.1 Europe Hemophilia A Drug Sales by Company (2016-2021)
7.1.2 Europe Hemophilia A Drug Revenue by Company (2016-2021)
7.2 Europe Hemophilia A Drug Sales Breakdown by Type
7.2.1 Europe Hemophilia A Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hemophilia A Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Hemophilia A Drug Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Hemophilia A Drug Market Facts & Figures
8.1 China Hemophilia A Drug Sales by Company
8.1.1 China Hemophilia A Drug Sales by Company (2016-2021)
8.1.2 China Hemophilia A Drug Revenue by Company (2016-2021)
8.2 China Hemophilia A Drug Sales Breakdown by Type
8.2.1 China Hemophilia A Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Hemophilia A Drug Sales Breakdown by Type (2022-2027)
8.3 China Hemophilia A Drug Sales Breakdown by Application
8.3.1 China 165 Sales Breakdown by Application (2016-2021)
8.3.2 China 165 Sales Breakdown by Application (2022-2027)

9 Japan Hemophilia A Drug Market Facts & Figures
9.1 Japan Hemophilia A Drug Sales by Company
9.1.1 Japan Hemophilia A Drug Sales by Company (2016-2021)
9.1.2 Japan Hemophilia A Drug Revenue by Company (2016-2021)
9.2 Japan Hemophilia A Drug Sales Breakdown by Type
9.2.1 Japan Hemophilia A Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hemophilia A Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Hemophilia A Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Hemophilia A Drug Market Facts & Figures
10.1 Southeast Asia Hemophilia A Drug Sales by Company
10.1.1 Southeast Asia Hemophilia A Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Hemophilia A Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Hemophilia A Drug Sales Breakdown by Type
10.2.1 Southeast Asia Hemophilia A Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hemophilia A Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hemophilia A Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Hemophilia A Drug Market Facts & Figures
11.1 India Hemophilia A Drug Sales by Company
11.1.1 India Hemophilia A Drug Sales by Company (2016-2021)
11.1.2 India Hemophilia A Drug Revenue by Company (2016-2021)
11.2 India Hemophilia A Drug Sales Breakdown by Type
11.2.1 India Hemophilia A Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Hemophilia A Drug Sales Breakdown by Type (2022-2027)
11.3 India Hemophilia A Drug Sales Breakdown by Application
11.3.1 India Hemophilia A Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Hemophilia A Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Hemophilia A Drug Business
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Business Overview
12.1.3 Bayer AG Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer AG Hemophilia A Drug Products Offered
12.1.5 Bayer AG Recent Development
12.2 BioMarin Pharmaceutical Inc
12.2.1 BioMarin Pharmaceutical Inc Corporation Information
12.2.2 BioMarin Pharmaceutical Inc Business Overview
12.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Products Offered
12.2.5 BioMarin Pharmaceutical Inc Recent Development
12.3 Bioverativ Inc
12.3.1 Bioverativ Inc Corporation Information
12.3.2 Bioverativ Inc Business Overview
12.3.3 Bioverativ Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bioverativ Inc Hemophilia A Drug Products Offered
12.3.5 Bioverativ Inc Recent Development
12.4 Catalyst Biosciences Inc
12.4.1 Catalyst Biosciences Inc Corporation Information
12.4.2 Catalyst Biosciences Inc Business Overview
12.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Catalyst Biosciences Inc Hemophilia A Drug Products Offered
12.4.5 Catalyst Biosciences Inc Recent Development
12.5 Chugai Pharmaceutical Co Ltd
12.5.1 Chugai Pharmaceutical Co Ltd Corporation Information
12.5.2 Chugai Pharmaceutical Co Ltd Business Overview
12.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Products Offered
12.5.5 Chugai Pharmaceutical Co Ltd Recent Development
12.6 CSL Ltd
12.6.1 CSL Ltd Corporation Information
12.6.2 CSL Ltd Business Overview
12.6.3 CSL Ltd Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CSL Ltd Hemophilia A Drug Products Offered
12.6.5 CSL Ltd Recent Development
12.7 DBV Technologies SA
12.7.1 DBV Technologies SA Corporation Information
12.7.2 DBV Technologies SA Business Overview
12.7.3 DBV Technologies SA Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 DBV Technologies SA Hemophilia A Drug Products Offered
12.7.5 DBV Technologies SA Recent Development
12.8 Dimension Therapeutics Inc
12.8.1 Dimension Therapeutics Inc Corporation Information
12.8.2 Dimension Therapeutics Inc Business Overview
12.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dimension Therapeutics Inc Hemophilia A Drug Products Offered
12.8.5 Dimension Therapeutics Inc Recent Development
12.9 EpiVax Inc
12.9.1 EpiVax Inc Corporation Information
12.9.2 EpiVax Inc Business Overview
12.9.3 EpiVax Inc Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 EpiVax Inc Hemophilia A Drug Products Offered
12.9.5 EpiVax Inc Recent Development
12.10 Expression Therapeutics LLC
12.10.1 Expression Therapeutics LLC Corporation Information
12.10.2 Expression Therapeutics LLC Business Overview
12.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Expression Therapeutics LLC Hemophilia A Drug Products Offered
12.10.5 Expression Therapeutics LLC Recent Development
12.11 Green Cross Corp
12.11.1 Green Cross Corp Corporation Information
12.11.2 Green Cross Corp Business Overview
12.11.3 Green Cross Corp Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Green Cross Corp Hemophilia A Drug Products Offered
12.11.5 Green Cross Corp Recent Development
12.12 Idogen AB
12.12.1 Idogen AB Corporation Information
12.12.2 Idogen AB Business Overview
12.12.3 Idogen AB Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Idogen AB Hemophilia A Drug Products Offered
12.12.5 Idogen AB Recent Development
12.13 Immusoft Corp
12.13.1 Immusoft Corp Corporation Information
12.13.2 Immusoft Corp Business Overview
12.13.3 Immusoft Corp Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Immusoft Corp Hemophilia A Drug Products Offered
12.13.5 Immusoft Corp Recent Development
12.14 LFB SA
12.14.1 LFB SA Corporation Information
12.14.2 LFB SA Business Overview
12.14.3 LFB SA Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 LFB SA Hemophilia A Drug Products Offered
12.14.5 LFB SA Recent Development
12.15 mAbxience SA
12.15.1 mAbxience SA Corporation Information
12.15.2 mAbxience SA Business Overview
12.15.3 mAbxience SA Hemophilia A Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 mAbxience SA Hemophilia A Drug Products Offered
12.15.5 mAbxience SA Recent Development

13 Hemophilia A Drug Manufacturing Cost Analysis
13.1 Hemophilia A Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hemophilia A Drug
13.4 Hemophilia A Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hemophilia A Drug Distributors List
14.3 Hemophilia A Drug Customers

15 Market Dynamics
15.1 Hemophilia A Drug Market Trends
15.2 Hemophilia A Drug Drivers
15.3 Hemophilia A Drug Market Challenges
15.4 Hemophilia A Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Hemophilia A Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hemophilia A Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hemophilia A Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hemophilia A Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Hemophilia A Drug Sales Market Share by Region (2016-2021)
Table 6. Global Hemophilia A Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hemophilia A Drug Revenue Share by Region (2016-2021)
Table 8. Global Hemophilia A Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Hemophilia A Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hemophilia A Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hemophilia A Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hemophilia A Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Hemophilia A Drug Sales Share by Company (2016-2021)
Table 14. Global Hemophilia A Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hemophilia A Drug Revenue Share by Company (2016-2021)
Table 16. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia A Drug as of 2020)
Table 17. Global Hemophilia A Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Hemophilia A Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Hemophilia A Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hemophilia A Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Hemophilia A Drug Sales Share by Type (2016-2021)
Table 23. Global Hemophilia A Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hemophilia A Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Hemophilia A Drug Sales Share by Type (2022-2027)
Table 26. Global Hemophilia A Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hemophilia A Drug Revenue Share by Type (2022-2027)
Table 28. Global Hemophilia A Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Hemophilia A Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Hemophilia A Drug Sales Share by Application (2016-2021)
Table 31. Global Hemophilia A Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hemophilia A Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Hemophilia A Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Hemophilia A Drug Sales Share by Application (2022-2027)
Table 35. Global Hemophilia A Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hemophilia A Drug Revenue Share by Application (2022-2027)
Table 37. Global Hemophilia A Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Hemophilia A Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Hemophilia A Drug Sales Market Share by Company (2016-2021)
Table 40. North America Hemophilia A Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hemophilia A Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Hemophilia A Drug Sales Market Share by Type (2016-2021)
Table 44. North America Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Hemophilia A Drug Sales Market Share by Type (2022-2027)
Table 46. North America Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Hemophilia A Drug Sales Market Share by Application (2016-2021)
Table 48. North America Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Hemophilia A Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Hemophilia A Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Hemophilia A Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Hemophilia A Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hemophilia A Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Hemophilia A Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Hemophilia A Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Hemophilia A Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Hemophilia A Drug Sales Market Share by Application (2022-2027)
Table 62. China Hemophilia A Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Hemophilia A Drug Sales Market Share by Company (2016-2021)
Table 64. China Hemophilia A Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hemophilia A Drug Revenue Market Share by Company (2016-2021)
Table 66. China Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Hemophilia A Drug Sales Market Share by Type (2016-2021)
Table 68. China Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Hemophilia A Drug Sales Market Share by Type (2022-2027)
Table 70. China Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Hemophilia A Drug Sales Market Share by Application (2016-2021)
Table 72. China Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Hemophilia A Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Hemophilia A Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Hemophilia A Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Hemophilia A Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hemophilia A Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Hemophilia A Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Hemophilia A Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Hemophilia A Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Hemophilia A Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hemophilia A Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Hemophilia A Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hemophilia A Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hemophilia A Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Hemophilia A Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Hemophilia A Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Hemophilia A Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Hemophilia A Drug Sales Market Share by Application (2022-2027)
Table 98. India Hemophilia A Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Hemophilia A Drug Sales Market Share by Company (2016-2021)
Table 100. India Hemophilia A Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hemophilia A Drug Revenue Market Share by Company (2016-2021)
Table 102. India Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Hemophilia A Drug Sales Market Share by Type (2016-2021)
Table 104. India Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Hemophilia A Drug Sales Market Share by Type (2022-2027)
Table 106. India Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Hemophilia A Drug Sales Market Share by Application (2016-2021)
Table 108. India Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Hemophilia A Drug Sales Market Share by Application (2022-2027)
Table 110. Bayer AG Corporation Information
Table 111. Bayer AG Description and Business Overview
Table 112. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Bayer AG Hemophilia A Drug Product
Table 114. Bayer AG Recent Development
Table 115. BioMarin Pharmaceutical Inc Corporation Information
Table 116. BioMarin Pharmaceutical Inc Description and Business Overview
Table 117. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. BioMarin Pharmaceutical Inc Hemophilia A Drug Product
Table 119. BioMarin Pharmaceutical Inc Recent Development
Table 120. Bioverativ Inc Corporation Information
Table 121. Bioverativ Inc Description and Business Overview
Table 122. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Bioverativ Inc Hemophilia A Drug Product
Table 124. Bioverativ Inc Recent Development
Table 125. Catalyst Biosciences Inc Corporation Information
Table 126. Catalyst Biosciences Inc Description and Business Overview
Table 127. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Catalyst Biosciences Inc Hemophilia A Drug Product
Table 129. Catalyst Biosciences Inc Recent Development
Table 130. Chugai Pharmaceutical Co Ltd Corporation Information
Table 131. Chugai Pharmaceutical Co Ltd Description and Business Overview
Table 132. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product
Table 134. Chugai Pharmaceutical Co Ltd Recent Development
Table 135. CSL Ltd Corporation Information
Table 136. CSL Ltd Description and Business Overview
Table 137. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. CSL Ltd Hemophilia A Drug Product
Table 139. CSL Ltd Recent Development
Table 140. DBV Technologies SA Corporation Information
Table 141. DBV Technologies SA Description and Business Overview
Table 142. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. DBV Technologies SA Hemophilia A Drug Product
Table 144. DBV Technologies SA Recent Development
Table 145. Dimension Therapeutics Inc Corporation Information
Table 146. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Dimension Therapeutics Inc Description and Business Overview
Table 148. Dimension Therapeutics Inc Hemophilia A Drug Product
Table 149. Dimension Therapeutics Inc Recent Development
Table 150. EpiVax Inc Corporation Information
Table 151. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. EpiVax Inc Description and Business Overview
Table 153. EpiVax Inc Hemophilia A Drug Product
Table 154. EpiVax Inc Recent Development
Table 155. Expression Therapeutics LLC Corporation Information
Table 156. Expression Therapeutics LLC Description and Business Overview
Table 157. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Expression Therapeutics LLC Hemophilia A Drug Product
Table 159. Expression Therapeutics LLC Recent Development
Table 160. Green Cross Corp Corporation Information
Table 161. Green Cross Corp Description and Business Overview
Table 162. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Green Cross Corp Hemophilia A Drug Product
Table 164. Green Cross Corp Recent Development
Table 165. Idogen AB Corporation Information
Table 166. Idogen AB Description and Business Overview
Table 167. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Idogen AB Hemophilia A Drug Product
Table 169. Idogen AB Recent Development
Table 170. Immusoft Corp Corporation Information
Table 171. Immusoft Corp Description and Business Overview
Table 172. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Immusoft Corp Hemophilia A Drug Product
Table 174. Immusoft Corp Recent Development
Table 175. LFB SA Corporation Information
Table 176. LFB SA Description and Business Overview
Table 177. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. LFB SA Hemophilia A Drug Product
Table 179. LFB SA Recent Development
Table 180. mAbxience SA Corporation Information
Table 181. mAbxience SA Description and Business Overview
Table 182. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. mAbxience SA Hemophilia A Drug Product
Table 184. mAbxience SA Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Hemophilia A Drug Distributors List
Table 188. Hemophilia A Drug Customers List
Table 189. Hemophilia A Drug Market Trends
Table 190. Hemophilia A Drug Market Drivers
Table 191. Hemophilia A Drug Market Challenges
Table 192. Hemophilia A Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia A Drug Product Picture
Figure 2. Global Hemophilia A Drug Sales Market Share by Type in 2021 & 2027
Figure 3. ATXF-8117 Product Picture
Figure 4. BAY-1093884 Product Picture
Figure 5. BIVV-001 Product Picture
Figure 6. BS-027125 Product Picture
Figure 7. Concizumab Product Picture
Figure 8. CSL-689 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Hemophilia A Drug Sales Market Share by Application in 2021 & 2027
Figure 11. Clinic Examples
Figure 12. Hospital Examples
Figure 13. ASCs Examples
Figure 14. Global Hemophilia A Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hemophilia A Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Hemophilia A Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global Hemophilia A Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global Hemophilia A Drug Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Hemophilia A Drug Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Hemophilia A Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Hemophilia A Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe Hemophilia A Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Hemophilia A Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Hemophilia A Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Hemophilia A Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Hemophilia A Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Hemophilia A Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Hemophilia A Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Hemophilia A Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Hemophilia A Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Hemophilia A Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Hemophilia A Drug Players Market Share by Revenue in Hemophilia A Drug: 2016 & 2020
Figure 33. Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Hemophilia A Drug Revenue Share by Type (2016-2021)
Figure 35. Global Hemophilia A Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Hemophilia A Drug Revenue Share by Application (2016-2021)
Figure 37. Global Hemophilia A Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Hemophilia A Drug Sales Market Share by Type in 2020
Figure 39. North America Hemophilia A Drug Sales Market Share by Application in 2020
Figure 40. Europe Hemophilia A Drug Sales Market Share by Type in 2020
Figure 41. Europe Hemophilia A Drug Sales Market Share by Application in 2020
Figure 42. China Hemophilia A Drug Sales Market Share by Type in 2020
Figure 43. China Hemophilia A Drug Sales Market Share by Application in 2020
Figure 44. Japan Hemophilia A Drug Sales Market Share by Type in 2020
Figure 45. Japan Hemophilia A Drug Sales Market Share by Application in 2020
Figure 46. Southeast Asia Hemophilia A Drug Sales Market Share by Type in 2020
Figure 47. Southeast Asia Hemophilia A Drug Sales Market Share by Application in 2020
Figure 48. India Hemophilia A Drug Sales Market Share by Type in 2020
Figure 49. India Hemophilia A Drug Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Hemophilia A Drug
Figure 52. Manufacturing Process Analysis of Hemophilia A Drug
Figure 53. Hemophilia A Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed